Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Geoffrey L Rogers
Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Major Role of Local Immune Responses in Antibody Formation to Factor IX in AAV Gene Transfer
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Engineered Factor VII, Factor IX, and Factor X Variants for Hemophilia Gene Therapy
Journal of Genetic Syndromes & Gene Therapy
244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
823. Factor IX Expression in Skeletal Muscle of a Subject With Severe Hemophilia B Ten Years After AAV Gene Transfer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
AAV-mediated Gene Transfer for Hemophilia
Genetics in Medicine
Medicine
Genetics
Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Immune Responses to Gene Therapy Vectors: Influence on Vector Function and Effector Mechanisms
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Anti-Cd20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice
Frontiers in Immunology
Allergy
Immunology
Molecular Basis of Hemophilia B: Identification of the Defect in Factor Ix Vancouver